A novel class of potent and selective phosphodiesterase 5 (PDE5) inhibitors, 4-aryl-1- isoquinolinone derivatives, which have been designed by the comparison of the structure of cGMP and a previously reported 1-arylnaphthalene lignan, was disclosed. Among these